Argenica Therapeutics (ASX:AGN) Price-to-Tangible-Book : 10.68 (As of May. 25, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Argenica Therapeutics Price-to-Tangible-Book?

As of today (2024-05-25), Argenica Therapeutics's share price is A$0.705. Argenica Therapeutics's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was A$0.07. Hence, Argenica Therapeutics's Price to Tangible Book Ratio of today is 10.68.

The historical rank and industry rank for Argenica Therapeutics's Price-to-Tangible-Book or its related term are showing as below:

ASX:AGN' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 2.13 Med: 5.22 Max: 11.44
Current: 10.07

During the past 3 years, Argenica Therapeutics's highest Price to Tangible Book Ratio was 11.44. The lowest was 2.13. And the median was 5.22.

ASX:AGN's Price-to-Tangible-Book is ranked worse than
87.98% of 1223 companies
in the Biotechnology industry
Industry Median: 2.78 vs ASX:AGN: 10.07

A closely related ratio is called PB Ratio. As of today, Argenica Therapeutics's share price is A$0.705. Argenica Therapeutics's Book Value per Sharefor the quarter that ended in Dec. 2023 was A$0.07. Hence, Argenica Therapeutics's P/B Ratio of today is 10.52.

Argenica Therapeutics Price-to-Tangible-Book Historical Data

The historical data trend for Argenica Therapeutics's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Argenica Therapeutics Price-to-Tangible-Book Chart

Argenica Therapeutics Annual Data

Trend

Jun21

Jun22

Jun23

Price-to-Tangible-Book

2.13

4.48

4.81

Argenica Therapeutics Semi-Annual Data
	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Price-to-Tangible-Book	Get a 7-Day Free Trial			11.44	4.48	5.63	4.81	7.73

Competitive Comparison of Argenica Therapeutics's Price-to-Tangible-Book

For the Biotechnology subindustry, Argenica Therapeutics's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Argenica Therapeutics's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Argenica Therapeutics's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Argenica Therapeutics's Price-to-Tangible-Book falls into.

Argenica Therapeutics Price-to-Tangible-Book Calculation

Argenica Therapeutics's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2023 )
	=	0.705	/	0.066
	=	10.68

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Argenica Therapeutics Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Argenica Therapeutics's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Argenica Therapeutics (ASX:AGN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Argenica Therapeutics Ltd (ASX:AGN) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

N/A

Address

117 Broadway, Unit 4, Nedlands, WA, AUS, 6009

Website

https://www.argenica.com.au

Argenica Therapeutics Ltd is engaged in the development and commercialization of novel drug candidates. Its ARG007 drug improves outcomes in pre-clinical stroke models and is in the process of being verified for its safety and toxicology before commencing Phase 1 clinical trials in humans.

Argenica Therapeutics (ASX:AGN) Headlines

No Headlines